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Bub1 is a component of the spindle assembly
checkpoint (SAC), a surveillance mechanism
that ensures genome stability by delaying ana-
phase until all the chromosomes are stably
attached to spindle microtubules via their
kinetochores. To define Bub1’s role in chromo-
some segregation, embryogenesis, and tissue
homeostasis, we generated a mouse strain in
which BUB1 can be inactivated by administra-
tion of tamoxifen, thereby bypassing the preim-
plantation lethality associatedwith theBub1null
phenotype. We show that Bub1 is essential for
postimplantation embryogenesis and prolife-
ration of primary embryonic fibroblasts. Bub1
inactivation in adult males inhibits proliferation
in seminiferous tubules, reducing sperm pro-
duction and causing infertility. In culture, Bub1-
deficient fibroblasts fail to align their chromo-
somes or sustain SAC function, yielding a highly
aberrant mitosis that prevents further cell divi-
sions. Centromeres in Bub1-deficient cells also
separate prematurely; however, we show that
this is a consequence of SAC dysfunction rather
than a direct role for Bub1 in protecting centro-
meric cohesion.
INTRODUCTION
The spindle assembly checkpoint (SAC) is an inhibitory
signaling network that delays anaphase onset until all
the chromosomes are stably attached to spindle microtu-
bules via their kinetochores (Musacchio and Salmon,
2007). The SAC consists of ‘‘sensor’’ proteins such as
Bub1, Mad1, and Mps1; a ‘‘signal transducer’’ known as
the mitotic checkpoint complex (MCC), comprised of
BubR1, Bub3, Mad2, and Cdc20; and an ‘‘effector,’’
namely the anaphase promoting complex/ cyclosome
(APC/C), a E3 ubiquitin ligase that targets anaphase inhib-
itors for proteolysis (Peters, 2006).
The SAC is not essential in budding yeast (Hoyt et al.,
1991; Li and Murray, 1991), possibly because these cells566 Developmental Cell 13, 566–579, October 2007 ª2007 Elseenter mitosis with kinetochores already attached to micro-
tubules (Gillett et al., 2004). By contrast, in vertebrate cells
the SAC restrains normal mitotic progression (Taylor and
McKeon, 1997; Gorbsky et al., 1998; Kops et al., 2004;
Meraldi et al., 2004). Consistently, mice harboring homo-
zygous null mutations in the MCC components Mad2,
BubR1, and Bub3 die very early during embryogenesis
(Dobles et al., 2000; Kalitsis et al., 2000; Babu et al.,
2003; Wang et al., 2004). Likewise, ablation of CENP-E
and RAE1, genes that encode a checkpoint-associated
kinesin and a Bub3-related protein, respectively, also
cause early embryonic lethality (Putkey et al., 2002;
Babu et al., 2003).
Our understanding of the SAC in mammals has there-
fore largely been restricted to analysis of heterozygous
mice harboring one null and one wild-type allele. Mouse
embryo fibroblasts (MEFs) heterozygous for Mad2,
BubR1, Bub3, Rae1, or Cenp-E all show SAC defects
and increased levels of aneuploidy (Babu et al., 2003;
Weaver et al., 2003; Dai et al., 2004; Burds et al., 2005; Ka-
litsis et al., 2005). Heterozygous animals develop normally
but are predisposed to either spontaneous or carcinogen-
induced tumors. Hypomorphic mice expressing 11%
BubR1 are not tumor prone but exhibit a premature aging
phenotype, with isolated MEFs showing a penetrant SAC
defect and high levels of aneuploidy (Baker et al., 2004).
Bub3/Rae1 compound heterozygotes also age prema-
turely (Baker et al., 2006). These studies have been possi-
ble only because partial inhibition of MCC components
yields penetrant effects on the SAC, consistent with the
MCC being a stoichiometric inhibitor of the APC/C
(Musacchio and Salmon, 2007). Indeed, reducing Mad2
protein levels to 70% totally abrogates the SAC in HCT-
116 cells (Michel et al., 2001).
To define the role of the SAC sensor Bub1 in chromo-
some segregation, embryogenesis, and tissue homeosta-
sis, we set out to mutate the murineBUB1 gene. However,
in contrast to MCC components, partial inhibition of Bub1
does not yield penetrant effects: HCT-116 cells heterozy-
gous for BUB1 are not haploinsufficent (V.L. Johnson &
S.S.T., unpublished data), and RNAi-mediated repression
of Bub1 has produced conflicting reports. While one study
showed that Bub1 repression compromised the SAC
(Meraldi and Sorger, 2005), others observed a premature
loss of centromeric cohesion followed by SAC activationvier Inc.
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Conditional Inactivation of Bub1(Tang et al., 2004; Kitajima et al., 2005). In our hands, Bub1
RNAi only yielded a penetrant SAC-defect when Aurora B
activity was suppressed (Johnson et al., 2004; Morrow
et al., 2005). Whether these differences reflect variations
in repression levels and/or off-target RNAi effects is un-
clear. To avoid the ambiguities associated with partial
loss-of-function phenotypes while also overcoming the
problems associated with the early embryonic lethality
typical of the SAC nulls described thus far, we used
a Cre-LoxP-based approach to create a conditional null
BUB1 allele. Here, we demonstrate that Bub1 is essential
not only for early embryogenesis but also later during de-
velopment and for proliferation of MEFs in culture. By in-
activating Bub1 in adult males, we also show that Bub1
is essential for spermatogenesis and fertility.
RESULTS
Generation of Conditional and Null BUB1 Alleles
Using homologous recombination in mouse ES cells, we
flanked exons 7 and 8—which encode the Bub3 binding
domain (Taylor et al., 1998)—with LoxP recombination
sites to create the BUB1F allele (Figure 1A; see also the
Supplemental Data available with this article online).
Mice harboring this allele were then crossed with a Cre-
deleter strain to create a null allele, BUB1D. Genotypes
were confirmed by PCR and Southern blotting (Figures
1B, 1C, and 1D). While BUB1F could be bred to homozy-
gosity (Figure 1C and 1D), breeding the BUB1D allele to
homozygosity resulted in embryonic lethality (see below).
To confirm that BUB1D was indeed a null, we prepared
MEFs from 13.5-day BUB1F/D embryos and transduced
them with an adenovirus expressing Cre, thereby creating
BUB1D/D cells. Western blotting showed that Bub1 protein
was undetectable in BUB1D/D cells (Figure 1E). Blots
probed with N-terminal antibodies failed to detect any
truncation products in BUB1D/D cells (Figure S1), indicat-
ing that Bub1 coding sequence upstream of exon 6 is not
expressed. These observations demonstrate therefore
that BUB1F encodes a functional protein, that BUB1D is
indeed a null, and that BUB1 is an essential gene.
Homozygous BUB1 Null Embryos Die
Before Implantation
To determine when during development BUB1D/D animals
died, we used a nested PCR assay capable of genotyping
blastocysts and embryos cultured in vitro. While BUB1D/+
intercrosses failed to yield any BUB1D/D animals after day
E8.5, they were present at day E3.5 (Figure 2A). When
these blastocyst-stage embryos were grown in culture,
they hatched and attached to the dish; but by day
E10.5, only a few extraembryonic trophoblast cells were
apparent, and there was no obvious inner cell mass
(ICM, Figure 2B). By contrast, wild-type and BUB1D/+
blastocysts produced robust ICMs on a layer of tropho-
blasts. Confocal imaging of embryos cultured in vitro
then fixed on day E7.5 and stained to detect phospho-
histone H3 confirmed the presence of mitotic cells in theDevelopmICMs of control embryos but revealed no mitotic cells in
the BUB1D/D cultures (Figure 2C). These observations
confirm that BUB1D/D embryos die before implantation
and are entirely consistent with the phenotypes exhibited
by Mad2, Bub3, Cenp-E, Rae1, and BubR1 null embryos
(Dobles et al., 2000; Kalitsis et al., 2000; Putkey et al.,
2002; Babu et al., 2003; Wang et al., 2004).
Bub1 Is Required for Proliferation of Primary
Embryonic Fibroblasts
To study the role of Bub1 at later stages of development, in
adults, and in cultured cells, we crossed the Bub1 strains
with mice harboring an ERT-Cre transgene (Hayashi
and McMahon, 2002). This transgene constitutively
and ubiquitously expresses Cre fused to a mutated estro-
gen receptor, which responds to the artificial ligand
4-hydroxy-tamoxifen (OHT) rather than the endogenous
ligand, estrogen. In the absence of OHT, the ERT-Cre fu-
sion protein is sequestered in the cytoplasm; upon binding
of OHT, it translocates to the nucleus where it mediates
recombination of genomic LoxP sites. Following OHT
washout, the Cre-fusion returns to the cytoplasm thereby
limiting any nonspecific genomic damage (Loonstra et al.,
2001; Silver and Livingston, 2001). To validate the system,
we isolated BUB1F/+ and BUB1F/D MEFs containing ERT-
Cre and exposed them in culture to OHT for 24 hr. PCR
analysis of DNA from resulting cells showed very efficient
conversion of BUB1F to BUB1D (Figure 3A). Furthermore,
western blotting demonstrated a dramatic reduction of
Bub1 protein in OHT-treatedBUB1F/D cultures (Figure 3B);
immunofluorescence analysis demonstrated that the
majority of mitotic cells were completely devoid of
kinetochore-bound Bub1 (Figure S2).
Having established that we could efficiently inactivate
Bub1 in culture, we asked whether Bub1 was required
for proliferation of primary embryonic fibroblasts.
BUB1F/+ and BUB1F/D MEFs containing ERT-Cre were
plated at 80% confluency and cultured for 2 days to in-
duce contact inhibition (Figure 3C). OHT was added for
48 hr in low serum to reinforce the growth arrest and pro-
mote cellular uptake of the OHT. On day 4, the OHT was
removed, and the cultures expanded to alleviate the con-
tact inhibition and trigger proliferation. Importantly, this
synchronization regimen ensured that the cells did not
progress into mitosis during the OHT treatment, thereby
allowing us to study the first mitosis in the absence of
Bub1. Untreated BUB1F/D cultures proliferated normally
(Figure 3D) and by day 8, 96 hr after release from the G1
block, they displayed DNA content profiles typical of pro-
liferating cultures (Figure 3E). By contrast, treatingBUB1F/D
cultures with OHT had a potent antiproliferative effect
(Figure 3D); by day 8, the DNA content profiles had degen-
erated with many cells exhibiting sub-G1 and >4n DNA
contents (Figure 3E); and the interphase nuclei were also
highly distorted with abnormal lobes and micronuclei
(Figure 3F), hallmarks of aberrant chromosome segrega-
tion. Although OHT treatment reduced Bub1 protein levels
inBUB1F/+ cultures (Figure 3B), due to inactivation of the F
allele (Figure 3A), all the mitotic cells were Bub1-positiveental Cell 13, 566–579, October 2007 ª2007 Elsevier Inc. 567
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Conditional Inactivation of Bub1Figure 1. Creation of Conditional and Null BUB1 Alleles
(A) Schematic representations of (i) the Bub1 protein showing the N-terminal homology domain (N-THD), the Bub3-binding site/kinetochore locali-
zation domain (KLD), and the kinase domain; (ii) a portion of the BUB1 gene showing exons 4–14 and the EcoRI restriction sites (R); (iii) the targeting
vector showing the neo-tk cassette and LoxP sites; (iv) the structure of the correctly targeted allele; (v) the conditional allele (F for floxed); and (vi) the
null allele (D). Also shown are the EcoRI restriction fragments detected by probe a. Underlined numbers show PCR genotyping primers 1–4.568 Developmental Cell 13, 566–579, October 2007 ª2007 Elsevier Inc.
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Conditional Inactivation of Bub1Figure 2. Embryonic Lethality of BUB1D/D Embryos
(A) PCR genotyping of blastocyst DNA using primers 1 and 2 and 1 and 3, confirming the presence of homozygous null embryos at day 3.5, plus a table
showing the number of BUB1D/ D animals observed at the age of weaning (p21), postimplantation (E8.5 to E9.5), and at the blastocyst stage (E3.5)
following BUB1D/+ intercrosses.
(B) Phase contrast images of embryos harvested at day 3.5 and cultured in vitro for 7 days, plus PCR products obtained using primers 3 and 4 (upper
panel) and 1 and 3 (lower panel) confirming the genotypes. Images, taken at progressively lower magnification, show that in contrast to Bub1 null
embryos, the controls form a robust inner cell mass (ICM) upon a layer of trophoblast cells (T).
(C) Confocal images of embryos harvested at day 3.5 cultured in vitro for 4 days then fixed and stained to detect phospho-histone H3 (green) and the
DNA (red), plus PCR genotypes obtained using primers 3 and 4 (upper panel) and 1 and 3 (lower panel). Arrows indicate examples of mitotic cells; note
that cells in the BUB1D/ D embryo which stain weakly for phospho-histone H3 are interphase cells. Scale bar, 50 mm.due to the remaining wild-type allele (data not shown).
Importantly, the OHT-treated BUB1F/+ cultures pro-
liferated normally (data not shown), confirming that OHT-Developmmediated induction of Cre does not induce any overt
toxicity and that inactivating one BUB1 allele does not
yield a penetrant haploinsufficient phenotype.(B) Table showing the sizes of the PCR products generated by primers 1 and 2, 1 and 3, and 3 and 4 distinguishing the various genotypes.
(C) PCR products generated by amplifying tail snip DNA with the primers indicated. The asterisks indicate heteroduplexes formed by annealing of the
larger and smaller PCR products.
(D) Southern blot of EcoRI-digested tail DNA probed with probe a confirming the genotypes.
(E) Western blots of BUB1F/D MEFs infected with AdCre then probed to detect Bub1 and tubulin.ental Cell 13, 566–579, October 2007 ª2007 Elsevier Inc. 569
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Conditional Inactivation of Bub1Figure 3. Tamoxifen-Induced Inactivation of Bub1 Inhibits Proliferation of Embryonic Fibroblasts
(A and B)BUB1F/+ andBUB1F/DMEFs harboring ERT-Crewere treated with 0.1 and 1.0 mM OHT for 24 hr and then analyzed by PCR genotyping using
primers 1 and 3 (A) and western blotting (B).
(C–F) BUB1F/D ERT-Cre MEFs were plated at 80% confluency, cultured for 2 days then treated with 0.1 OHT for 48 hr. On day 4 the cultures were
expanded, the OHT removed, and the cells analyzed at subsequent time points. (C) Timeline showing experimental design. (D) Growth curves
showing antiproliferative effect following Bub1-inactivation. (E) DNA content histograms showing marked reduction of cells with 2n and 4n values.
(F) Fluorescence images of nuclei showing aberrant morphologies in Bub1 null cells.Bub1 Is Required for Chromosome Alignment
and SAC Function
Next, we analyzed the effect of Bub1-inactivation on SAC
function and chromosome segregation. Previously, we
showed that RNAi-mediated repression of Bub1 abolishes
kinetochore localization of BubR1 (Johnson et al., 2004).570 Developmental Cell 13, 566–579, October 2007 ª2007 ElseThis has since been challenged by others (Meraldi and
Sorger, 2005). Therefore, we analyzed BubR1 in BUB1F/D
cells treated with OHT. Importantly, BubR1 protein levels
were not affected following inactivation of Bub1 (Fig-
ure 4A). However, consistent with our previous obser-
vations, BubR1 did not localize to kinetochores in thevier Inc.
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Conditional Inactivation of Bub1absence of Bub1 (Figure 4B). To define Bub1’s require-
ment in SAC function, MEF cultures were challenged
with the mitotic kinesin Eg5 inhibitor monastrol to prevent
spindle assembly then analyzed by time-lapse micros-
copy. In the absence of monastrol, Bub1-proficient cells
completed mitosis within 1 hr (Figure 4C, OHT
Mon). When challenged with monastrol, Bub1-proficient
cells mounted a robust SAC response, delaying mitotic
exit for on average3.5 hr (Figure 4C,OHT +Mon). How-
ever, the vast majority of cells in the Bub1-deficient cul-
tures exited mitosis within 1 hr in both the presence
and absence of monastrol (Figure 4C, +OHT ±Mon).
Thus, while BUB1 inactivation does not accelerate normal
mitotic timing, it completely abolishes the SAC in re-
sponse to monastrol. Similarly, inactivation of BUB1 abro-
gated the SAC in MEFs exposed to the antitubulin agents,
nocodazole and taxol (Figure S3).
To confirm that the SAC-defect was indeed due to in-
activation of BUB1, we introduced a Myc-tagged Bub1
transgene into BUB1D/D cells using a recombinant adeno-
virus (Figure S4). While BUB1D/D cells infected with a con-
trol virus failed to mount a SAC response when challenged
with monastrol, BUB1D/D cells infected with Bub1 viruses
delayed mitotic exit by several hours (Figure 4D). Impor-
tantly, the ability of an exogenous Bub1 transgene to
rescue the SAC defect in BUB1D/D cells confirms that
the phenotype is indeed due to inactivation ofBUB1 rather
than a nonspecific effect caused by exposure to OHT or
activation of Cre. Note also that reconstituting Bub1
function in BUB1D/D cells restored BubR1 localization
(Figure 4B), further confirming that Bub1 is required for
kinetochore localization of BubR1.
Consistent with RNAi-based studies (Meraldi et al.,
2004; Morrow et al., 2005), BUB1 inactivation did not ac-
celerate normal mitotic timing. This suggests that Bub1-
deficient cells should have sufficient time to successfully
align and segregate their chromosomes. Yet, in the ab-
sence of Bub1, proliferation is dramatically inhibited (Fig-
ure 3), suggesting that mitosis might be aberrant despite
normal timing. To test this, we infected MEFs with a retro-
virus encoding a GFP-tagged histone and then visualized
chromosome movements by fluorescence time-lapse im-
aging. This revealed that chromosome segregation was
highly aberrant in over 90% of the OHT-treated BUB1F/D
cells (Figure 4E, Table S1). Two phenotypes were preva-
lent: either the chromosomes decondensed without any
obvious signs of chromosome alignment or anaphase
movement, yielding a single large nucleus; or alternatively,
the chromosomes moved poleward without forming a dis-
tinct metaphase plate, yielding lagging chromosomes,
chromosome bridges, and distorted nuclei. Thus, despite
normal mitotic timing, Bub1-deficient MEFs exit mitosis
without correctly aligning their chromosomes.
Analysis of K-Fibers in Bub1-Deficient Cells
The lack of any apparent poleward movement in 50% of
BUB1D/D cells suggested a severe impairment of kineto-
chore-microtubule interactions. Therefore, to ascertain
whether kinetochore fibers (K-fibers) form, BUB1F/D cellsDevelopmtreated with OHT were exposed to the proteasome inhib-
itor MG132 for 1 hr to arrest mitotic cells in metaphase.
The cells were then fixed to selectively preserve K-fibers
and stained to detect microtubules and chromosomes
(Figure 5A). We also stained for Bub1 (data not shown)
to ensure that the OHT-treated cells were indeed Bub1-
deficient. In control cells, perfect metaphases were readily
apparent with all the chromosomes aligned at the spindle
equator; closer inspection revealed bioriented chromo-
somes (Figure 5A). In Bub1-deficient cells, metaphases
were apparent, but they appeared more disorganized;
the metaphase plate appeared broader with some chro-
mosomes clustered near the spindle poles (Figure 5A).
Consistent with the majority of chromosomes being able
to align, K-fibers were readily apparent indicating that
kinetochore-microtubule interactions are not completely
inhibited in Bub1-deficient cells. Note that K-fibers were
also apparent in the absence of MG132 (data not shown).
Bub1 Maintains Sister Chromatid Cohesion
by Activation of the Spindle Checkpoint
The chromosome segregation failure in BUB1D/D cells
could also be explained by a premature centromere sep-
aration (PCS) due to a centromeric cohesion defect
(Tang et al., 2004; Kitajima et al., 2005). To ascertain
the status of centromeric cohesion in the absence of
Bub1, we treated BUB1F/D MEFs with OHT, added noco-
dazole, then prepared chromosome spreads. In controls,
all the chromosomes in 100% of the spreads had co-
hesed centromeres (Figure 5B, panels i and iv, n =
278). Treatment of controls with okadaic acid, a PP2A in-
hibitor, induced PCS in 56% of the cells (Figure 5B,
panel vi, n = 27), consistent with observations demon-
strating that PP2A sustains centromeric cohesion by tar-
geting Sgo1 to centromeres (Kitajima et al., 2006; Riedel
et al., 2006; Tang et al., 2006). In BUB1F/D MEFs treated
with OHT, the vast majority of chromosome spreads had
cohesed centromeres; PCS was obvious in only 11%
of the cells (Figure 5B panels ii and iii, n = 178). In the
example shown in Figure 5B, panel iii, all the sister cen-
tromeres appeared to be separated, as one would ex-
pect in a cell that had committed to anaphase, i.e.,
switched off the SAC, activated the APC/C, and de-
graded securin. Because these MEFs require Bub1 for
SAC function (Figure 4), we reasoned that the PCS could
be due to SAC override rather than a direct effect on
Sgo1-dependent protection of centromeric cohesion
(Tang et al., 2004; Kitajima et al., 2005). To test this,
we treated the MEFs with MG132 during the nocodazole
block. We predicted that if Bub1 maintained cohesion by
inhibiting securin proteolysis via APC/C-inhibition, then
in the presence of MG132, sisters should remain co-
hesed due to the inability to degrade securin. If by con-
trast Bub1 plays a direct role in protecting centromeric
cohesion independent of its role in the SAC, e.g., via
Sgo1 targeting, then inhibiting proteolysis would have
no effect and the centromeres should separate prema-
turely. Significantly, in the presence of MG132, we ob-
served no PCS in OHT-treated BUB1F/D MEFs; underental Cell 13, 566–579, October 2007 ª2007 Elsevier Inc. 571
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Conditional Inactivation of Bub1Figure 4. Bub1 Is Required for Kinetochore Targeting of BubR1 and SAC Function
Asynchronous BUB1F/D ERT-Cre MEFs were treated with 0.5 mM OHT for 24 hr then analyzed by western blotting, immunofluorescence, and time-
lapse microscopy. In (B) and (D), cells were preinfected with adenoviral vectors as indicated. In (E), cells were preinfected with retrovirus encoding
a GFP-tagged histone H2B.
(A) Western blots showing that BubR1 levels are unaffected following Bub1 inactivation. Tubulin was used as loading control.
(B) Projections of deconvolved image stacks showing that kinetochore localization of BubR1 requires Bub1. Scale bar, 5 mm.
(C and D) Line graphs plotting the percentage of cells in mitosis in the presence or absence of monastrol as indicated. The time in mitosis is defined as
the interval between nuclear envelope breakdown and chromosome decondensation, as determined by phase-contrast time-lapse analysis. At least
18 cells were analyzed in each condition.
(E) Fluorescence images from time-lapse sequences. Numbers represent minutes after NEBD.572 Developmental Cell 13, 566–579, October 2007 ª2007 Elsevier Inc.
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Conditional Inactivation of Bub1Figure 5. K-Fibers Form and Centromeric Cohesion Is Maintained in Bub1 Null Cells
(A) BUB1F/D ERT-CreMEFs were synchronized and exposed to 0.1 mM OHT as shown in Figure 3C. At T = 24 hr, the cells were treated with MG132 for
1 hr to arrest the cells downstream of the SAC, fixed to preserve K-fibers, and then stained to detect tubulin (green), Bub1 (not shown), and DNA (red).
Images show projections of deconvolved image stacks. Enlargement shows a mono-oriented chromosome in the Bub1 null cell. Scale bar, 5 mm.
(B) Asynchronous BUB1F/D ERT-Cre MEFs were treated with 0.5 mM OHT for 24 hr, exposed to nocodazole ± MG132 for 1 hr then chromosome
spreads prepared and scored for premature centromere separation (PCS). As a positive control, cells were treated with okadaic acid. Images and
enlargements show examples of spreads and individual chromosomes respectively. Percentages show the number of spreads represented by
that image.
(C) Bar graph quantitating the percentage of mitotic cells exhibiting PCS.these conditions, all the chromosomes in 100% of the
spreads analyzed had cohesed centromeres (Figure 5B,
panel v, n = 150). Furthermore, overexpression of a non-
degradable securin also prevented PCS in BUB1D/D
MEFs, confirming that Bub1 maintains centromeric co-
hesion by activation of the SAC (Figure 5C).DevelopmTamoxifen-Induced Inactivation of Bub1 in Adult
Males Causes Infertility
Having established that OHT-mediated induction of Cre
efficiently inactivated Bub1 in BUB1F/D MEFs, we asked
whether this approach could inactivate Bub1 in adult
mice. Interestingly, in contrast to Bub3, Bub1 was onlyental Cell 13, 566–579, October 2007 ª2007 Elsevier Inc. 573
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Conditional Inactivation of Bub1detectable in the testes of wild-type adults (Figure S5);
therefore, we focused on this particular tissue. BUB1F/F
males were injected with tamoxifen dissolved in corn oil,
and, as controls, we injected BUB1F/F males with corn
oil alone. In addition, we injected BUB1F/+ males with ei-
ther tamoxifen or corn oil (Table S2). Each male was in-
jected weekly for four consecutive weeks. To test fertility,
each male was housed with two wild-type females during
weeks 3 and 4. Although all the females presented vaginal
plugs after mating, no litters were obtained from matings
involving BUB1F/F males injected with tamoxifen (Table
S2). By contrast, BUB1F/F males injected with corn oil, or
BUB1F/+ males injected with either tamoxifen or corn oil,
all yielded litters. (Females that did not yield litters were
then mated with fertile males, confirming female fertility.)
The infertile males—which presented no overt phenotype
after 4 weeks of treatment—were then sacrificed and the
testes analyzed. PCR genotyping confirmed efficient con-
version of the F alleles toD (Figure 6A), while western blot-
ting demonstrated ablation of Bub1 protein in bothBUB1F/
D and BUB1F/F animals (Figure 6B).
To determine the cause of infertility, BUB1F/F males
were injected with tamoxifen every week for 8 weeks
and the testes then analyzed. Histological sections of
Bub1-deficient testis revealed major abnormalities, in-
cluding decreased cellularity and reduced diameter of
the tubules (Figure 6C). Tubules containing only Sertoli
cells were frequently observed, indicating that prolifera-
tion of the spermatogonia was inhibited and that germ
cells were no longer produced. As a consequence of ma-
jor alterations in the composition of the germ cell layer,
staging of the tubules in Bub1-deficient testis sections
was frequently impossible (Figure 6D). Furthermore, clus-
ters of M-phase cells and tubules with mature sperm cells
were less apparent following Bub1 inactivation (Figure S6,
Table S3). Where mitotic clusters were observed in Bub1-
deficient testes, abnormal anaphases were often appar-
ent (Figure 6D and Figure S6). Spermatocytes with abnor-
mal chromosome contents were also apparent (Figure S6).
Consistent with this dramatic effect, the weight of Bub1-
deficient testis was reduced by 50% (Figure S6), and
sperm production was reduced by over 80% (Figure S7).
Thus, inactivation of Bub1 in adult males impairs normal
chromosome segregation and inhibits spermatogenesis,
resulting in infertility.
Bub1 Is Required for Postimplantation
Development
Despite being infertile, BUB1F/F ERT-Cre males injected
with tamoxifen appeared largely normal. Although Cre-
mediated recombination was observed in tissues other
than testes (data not shown), it may have been less effi-
cient, leading to only partial inactivation of Bub1. Alterna-
tively, in contrast to the testes, most tissues in adult mice
consist of nondividing cells; these tissues may therefore
be less sensitive to Bub1-inactivation. Indeed, while we
could detect Bub3 in a variety of tissues, Bub1 was only
detectable in the testes (Figure S5). Therefore, to investi-
gate the effect of inactivating Bub1 in tissues containing574 Developmental Cell 13, 566–579, October 2007 ª2007 Elsea higher proportion of proliferating cells, we inactivated
Bub1 in postimplantation embryos by injecting tamoxifen
into pregnant females. Timed matings were set up be-
tween BUB1F/F males and BUB1D/+ females harboring
ERT-Cre (Figure 7A). The advantage of this mating regi-
men was two-fold. First, the resulting embryos would be
either BUB1F/D or BUB1F/+, in roughly equal proportions,
and harbor ERT-Cre. Second, because the female lacks
F alleles, tamoxifen-mediated induction of Cre should
have no effect in the pregnant host. Ten and a half days
post coitum (p.c.), the female was injected with tamoxifen,
then 18.5 days p.c., the embryos were harvested and
genotyped, identifying fiveBUB1F/+ and fourBUB1F/D em-
bryos (Figure 7B). While the BUB1F/+ embryos appeared
as one would expect for 18.5 day embryos, i.e., com-
pletely normal, the BUB1F/D embryos were clearly abnor-
mal (Figure 7C). Specifically, in both size and shape they
appeared similar to embryos normally found at day
E10.5–E11.5 (Nagy et al., 2003). Whether these develop-
mentally arrested embryos were alive or dead at day
18.5 is unclear; indeed, we were surprised that the abnor-
mal embryos were not resorbed. Defining which cells
express Bub1 during embryogenesis, the frequency of
BUB1 inactivation and the cause of the developmental
arrest will require further analysis.
DISCUSSION
Here we describe, for the first time, the phenotype of
mammalian cells, tissues, and embryos rendered homo-
zygous null for Bub1. We show that Bub1 is essential for
early embryogenesis, with BUB1D/D animals dying be-
tween day E3.5 and E8.5. Lethality at this time, which oc-
curs in all homozygous SAC mutants examined to date
(Dobles et al., 2000; Kalitsis et al., 2000; Putkey et al.,
2002; Babu et al., 2003; Wang et al., 2004; Iwanaga
et al., 2007), may reflect the very rapid cell divisions that
occur in the early embryo (Nagy et al., 2003). To overcome
early embryonic lethality, we used a Cre-LoxP-based ap-
proach to inactivate Bub1 at later developmental stages.
Tamoxifen-induced gene ablation in postimplantation
embryos shows that Bub1 is also essential following
gastrulation and the initiation of organogenesis: day 10.5
embryos arrest development shortly after Bub1 inactiva-
tion. Bub1 is also required for proliferation of primary em-
bryonic fibroblasts isolated at day E13.5. In the absence of
Bub1, MEFs undergo one highly aberrant mitosis, but the
marked reduction in cell number, plus the paucity of
mitotic cells at later time points, suggests that they do
not divide again. The ability to inactivate Bub1 by small
molecule exposure has also allowed us to study Bub1
function in adult tissues. Tamoxifen-induced inactivation
of Bub1 occurred very efficiently in the testes, resulting
in infertility. Consistent with the antiproliferative effect
observed in embryos and cultured MEFs, phospho-
histone-H3-positive cells and mature spermatids were
less apparent in Bub1-deficient seminiferous tubules.
Thus, in the four different scenarios we have examined,
Bub1 is essential for cellular proliferation.vier Inc.
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matogenesis
Male mice harboring conditional Bub1 alleles
and the ERT-Cre transgene were injected with
tamoxifen, and the testes were isolated and
analyzed by PCR genotyping, western blotting,
and histology.
(A) PCR genotyping with primers 3 and 4 (upper
panel) and 1 and 3 (lower panel) demonstrating
efficient conversion of F alleles to D.
(B) Western blot confirming depletion of Bub1
protein in BUB1F/D and BUB1F/F males follow-
ing tamoxifen exposure.
(C) Hematoxylin/eosin-stained testes sections
showing aberrant tubule morphology in Bub1-
deficient testes. Scale bar, 100 mm.
(D) PAS/hematoxylin-stained tubules showing
that following tamoxifen treatment, tubules
are frequently abnormal and often cannot be
staged (asterisks). Roman numerals indicate
tubules in various stages of spermatogenesis,
arrows indicate anaphases.We also examined the effect of Bub1-inactivation on
chromosome segregation and SAC function. These issues
have previously been addressed by several RNAi-based
studies in HeLa cells, yielding conflicting reports. In two
studies, Bub1-repression induced Sgo1 mislocalization
and premature centromere separation, which in turn acti-
vated the SAC (Tang et al., 2004; Kitajima et al., 2005). In
our hands, repressing Bub1 by98% was not sufficient to
prevent mitotic arrest in response to spindle damage
(Johnson et al., 2004; Morrow et al., 2005). A fourth study
repressed Bub1 by 99.5% which was sufficient to over-
ride the SAC (Meraldi and Sorger, 2005); however, despite
more extensive repression in this latter study, BubR1 lo-Developmcalized to kinetochores depleted of Bub1, an observation
which is inconsistent with our previous analysis (Johnson
et al., 2004). Our new data derived from Bub1 null MEFs
clarifies these issues. We confirm our earlier observation
that Bub1 is indeed required to target BubR1 to kineto-
chores. In addition, we show that Bub1 is required to
prevent anaphase onset in the presence of unaligned
chromosomes and mitotic exit when spindle assembly is
compromised.
We also observed premature centromere separation in
Bub1 null cells. However, having unambiguously demon-
strated that Bub1 is required for SAC function, we were
concerned that this might be due to SAC-override ratherental Cell 13, 566–579, October 2007 ª2007 Elsevier Inc. 575
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Conditional Inactivation of Bub1Figure 7. Bub1 Is Required for Postim-
plantation Embryo Development
A BUB1F/F ERT-Cre male was crossed with a
BUB1D/+ ERT-Cre female. Ten and a half days
p.c., the female was injected with tamoxifen
and then on day 18.5 p.c., the embryos were
harvested and genotyped.
(A) Schematic of mating regimen.
(B) PCR genotyping using primers 3 and 4 (up-
per panel) and 1 and 3 (middle panel) to confirm
the genotype and the presence of Cre (lower
panel). Note that recombination is not 100%
efficient, explaining the presence of F alleles
in tamoxifen-treated BUB1F/D embryos.
(C) Images of embryos shortly after harvesting
on day 18.5 showing arrested development in
theBUB1F/D animals. Scale bar, 5 mm. The ge-
notypes of the F/+ and F/D embryos are shown
in lanes 1–5 and 6–9, respectively, in panel B.than a direct effect on Sgo1-mediated protection of centro-
meric cohesion (Tang et al., 2004; Kitajima et al., 2005). In-
deed, when we inhibited the proteasome or expressed a
nondegradable securin to prevent activation of separase
in Bub1-deficient cells, sister centromeres remained
cohesed. This is inconsistent with the notion that Bub1 pro-
tects centromeres from the ‘‘prophase pathway’’ which
removes cohesin from chromosome arms in a separase-in-
dependent manner (Tang et al., 2004; Kitajima et al., 2005).
Interestingly, an anti-Sgo1 antibody (Tang et al., 2004) dec-
orates kinetochores in MEFs, and this is abolished upon
Bub1 deletion (Figure S8). However, this antibody detects
several bands on MEF western blots (data not shown), so
we cannot be certain which Sgo1 isoform localizes to
mouse kinetochores in a Bub1-dependent manner. Never-
theless, despite the mislocalization of this Sgo1 isoform,
centromeric cohesion is maintained when proteolysis is in-
hibited. How can we explain these inconsistencies? First, in
the absence of an obvious SAC defect, the observed cen-
tromere separation might not have been considered to be576 Developmental Cell 13, 566–579, October 2007 ª2007 Elsa manifestation of SAC dysfunction; the effect of MG132
on centromere separation was not reported in the Bub1
RNAi studies (Tang et al., 2004; Kitajima et al., 2005). Sec-
ond, the differences may reflect differences between pri-
mary mouse fibroblasts and transformed human, epithe-
lial-derived cells. Third, the functional roles of Sgo-related
proteins do not appear to be restricted to protecting centro-
meric cohesion; Sgo2 has recently been shown to play
a role in regulating components of the chromosome pas-
senger complex (CPC) (Salic et al., 2004; Huang et al.,
2007; Kawashima et al., 2007; Vanoosthuyse et al., 2007).
Finally, because components of the RNAi machinery
are required for centromeric heterochromatin structure
(Fukagawa et al., 2004), RNAi-mediated repression of cen-
tromere/kinetochore proteins may result in synthetic
interactions that disrupt centromeric cohesion.
Despite the fact that all the homozygous null SAC mu-
tants described to date result in embryonic lethality, it
was recently suggested that the SAC is not essential in
mammals (Burds et al., 2005). This was based on theevier Inc.
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mice (Burds et al., 2005). Note, however, that these lines
are p53 deficient and arise infrequently; culturing 208 em-
bryos yielded only two lines. Furthermore, although Mad2
loss overrides the SAC and accelerates mitotic timing,
45% of these cells separate their chromosomes nor-
mally, and30% divide with only a single lagging chromo-
some, possibly explaining why these cells can give rise to
viable lines. By contrast, the effect of inactivating Bub1 is
very different; chromosome segregation is disastrous in
Bub1 null cells despite no obvious effect on mitotic timing.
Consistently, Bub1 is essential, not only in cultured pri-
mary fibroblasts but also in very early embryos, day 10.5
embryos, and during transmission of the male germline.
Indeed, in contrast to Mad2, Bub1’s function extends be-
yond the SAC. A role for Bub1 in chromosome congres-
sion—independent of its SAC function—has been alluded
to in yeast (Bernard et al., 1998; Warren et al., 2002; Kita-
jima et al., 2004). We showed that RNAi-mediated repres-
sion of Bub1 inhibits chromosome congression in HeLa
cells (Johnson et al., 2004), an observation later confirmed
by others (Meraldi and Sorger, 2005). In this latter case, in-
creased lateral and syntelic orientations were observed,
mal-orientations typically observed following CPC inhibi-
tion. It is possible therefore that, in contrast to the MCC
components, depletion of the checkpoint sensor Bub1
not only negates the SAC but also inhibits CPC activity,
possibly by compromising Shugoshin function, and
thereby inhibiting chromosome biorientation.
In summary, we show here that, in contrast to the other
SAC mutants described so far, mitosis is disastrous in
BUB1D/D cells due to a failure in both chromosome align-
ment and SAC function, resulting in potent antiproliferative
effects in culture, during embryogenesis, and in adult tis-
sues. By contrast, heterozygous BUB1 animals and MEFs
did not exhibit any overt abnormalities. This is consistent
with the lack of penetrant effects in RNAi-based experi-
ments (Johnson et al., 2004; Morrow et al., 2005), highlight-
ing the limitation of RNAi when studying protein kinases
which concentrate at discrete subcellular localizations.
The conditional BUB1 strain described here has not only
allowed us to generate bona fide Bub1 null cells, but by
introducing a tamoxifen-inducible Cre, we have avoided
the early embryonic lethality exhibited by all of the SAC
mutant mice described thus far. This system will now allow
us to further explore the role of Bub1 in development, tissue
homeostasis, tumorigenesis, and aging.
EXPERIMENTAL PROCEDURES
Construction of Mouse Strains
A mouse genomic library was screened with an mBub1 cDNA fragment
(Taylor and McKeon, 1997), and the isolated clones were then mapped
and sequenced. To generate the targeting vector, fragments contain-
ing exons 5–8 and 9 were cloned into a pKO-derived vector (Strata-
gene) (Figure 1A). A LoxP site was engineered upstream of exon 7,
and a LoxP-neo-tk-LoxP cassette was then inserted downstream of
exon 8. The construct was linearized and electroporated into ES cells;
Southern blotting with probe a (Figure 1A) was then used to identify
correctly targeted clones. The neo-tk cassette was then removed byDevelopmtransient transfection of Cre. BUB1F/+ ES cells were injected into
C57BL/6J blastocysts to generate BUB1F/+ animals. BUB1F/+ mice
were crossed with a deleter Cre line to create the D allele. To distin-
guish between the different alleles, tail snip DNA was PCR genotyped
using primers 1, 2, 3, and 4 (Figures 1A and 1B and Table S4). The
ERT-Cre transgenic line was obtained from Jackson Laboratories
(Bar Harbor, USA), and the presence of the transgene was confirmed
by PCR (Table S4). All mice were hosted in a pathogen-free facility at
the University of Manchester. For more details see the Supplemental
Data.
Isolation and Culture of Embryos and Mouse
Embryo Fibroblasts
Three and a half day embryos were isolated from superovulated fe-
males, placed in gelatin-coated plates, and cultured in DMEM plus
15% fetal calf serum, 100 U/ml penicillin, 100 mg/ml streptomycin,
and 2 mM glutamine (Invitrogen). To genotype blastocysts and in vitro
embryo cultures, nested PCR was performed using primers 10, 20, 30,
and 40 (Table S4) followed by primers 1–4 as described above. MEFs
from 13.5 d embryos were prepared using standard procedures
(Nagy et al., 2003), then cultured in gelatin-coated flasks as above
but in 10% serum and 3% oxygen. To induce Cre, MEFs were cultured
in optiMEM media (Invitrogen) plus 2% charcoal/dextran-treated
serum (Hyclone); 4-hydroxy-tamoxifen (Sigma, 10 mg/ml stock in
ethanol) was added at 0.1 or 0.5 mM. Nocodazole, taxol, and MG132
were used at final concentrations of 0.2 mg/ml, 10 mM, and 20 mM,
respectively. Okadaic acid (Calbiochem) and monastrol (Sigma) were
used at final concentrations of 10 mM and 100 mM, respectively.
Cell Biology
For western blotting, proteins were extracted in lysis buffer (10 mM Tris
pH 7.4, 100 mM NaCl, 1 mM EDTA, 1 mM EGTA, 0.1% Triton X-100,
10 mM b-glycerophosphate, 1 mM DTT, 0.2 mM PMSF, and protease
inhibitors), transferred to nitrocellulose membranes, blocked in TBST
(50 mM Tris, pH 7.6, 150 mM NaCl, 0.1% Tween-20) plus 5% nonfat
dried milk, and probed with the following antibodies: SB1.3 (sheep
anti-Bub1, 1:1,000 [Taylor et al., 2001]), SBR1.1 (sheep anti-BubR1,
1:1,000, [Taylor et al., 2001]), and TAT1 (mouse anti-tubulin, 1:5,000,
gift from Keith Gull, Oxford). For immunofluorescence analysis, cells
and embryos were fixed in PBS plus 1% formaldehyde, permeabilized
in 0.1% Triton X-100, and then stained with the following primary anti-
bodies: 4B12 (mouse anti-Bub1, 1:10, [Taylor and McKeon, 1997]),
SBR1.1 (1:100), TAT1 (1:200), and rabbit anti-phospho-histone H3
(serine 10, 1:200, Upstate Biotechnology). To preserve K-fibers, cells
were permeabilized for 90 s in K-buffer (100 mM PIPES pH 6.8,
1 mM MgCl, 0.1 mM CaCl2, 0.1% Triton X-100) at room temperature,
fixed for 10 min in 4% formaldehyde diluted in K-buffer, and then pro-
cessed as above. Widefield microscopy, deconvolution, and imaging
processing were all done as described (Taylor et al., 2001). Confocal
imaging of embryos was performed using a Leica SP2 AOBS micro-
scope. To prepare chromosome spreads, MEFs were treated with no-
codazole for 5 hr, incubated in hypotonic buffer for 30 min, then fixed
in fresh Carnoy’s solution (methanol/acetic acid, 3:1). Chromosomes
were spread on glass slides, air-dried, and stained with Hoechst
33358 (Sigma). Flow cytometry was done as described (Taylor et al.,
2001) using a Cyan (DakoCytomation). Growth curves using the crystal
violet method were as described (Hussein and Taylor, 2002). Time-
lapse microscopy was done as described previously (Morrow et al.,
2005), acquiring images every 2 minutes. XY point visiting was per-
formed using a PZ-2000 automated stage (Applied Scientific Instru-
mentation).
Viral Infections
The adenovirus expressing Cre was purchased from Microbix Bio-
systems, Inc. (Canada). Recombinant adenoviruses expressing a
Myc-tagged mBub1 transgene were generated using the AdEasy sys-
tem (Stratagene) according to the manufacturer’s instructions. MEF
cultures were infected with an MOI of 100, with LacZ viruses servingental Cell 13, 566–579, October 2007 ª2007 Elsevier Inc. 577
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tagged histone H2B (Morrow et al., 2005) or a Myc-tagged securin
D-box/KEN box double mutant (Hagting et al., 2002) were cloned
into a pLPCX-based vector (Hussein and Taylor, 2002). The resulting
plasmids were transfected into Phoenix-Eco packaging cells (kindly
provided by Gary Nolan, Stanford) using the calcium phosphate
method. Subconfluent cultures were incubated overnight in the ab-
sence of serum, the viral supernatant harvested, passed through
a 0.2 mm filter, and CaCl2 and polybrene added to final concentrations
of 4 mM and 4 mg/ml, respectively. Viruses were then added to MEFs
for 24 hr.
In Vivo Inactivation of Bub1
Adult males were injected (i.p.) once a week for 4 or 8 weeks with
tamoxifen (Sigma, 5 mg per 40 g body weight) dissolved in corn oil
(Sigma). For western blotting, the outer capsule was removed from
one testis, and the remaining tissue was finely chopped and washed
with PBS. Samples were lysed with 6 M urea, 1% SDS, 0.1% b-mer-
captoethanol, and 20 mM Tris pH 6.8; sonicated and centrifuged for
5 min at 13,000 rpm; and the supernatants collected for analysis.
Protein samples were subjected to SDS-PAGE and then transferred
to nitrocellulose. For histological analysis, testes and epididymides
were dissected and fixed in Bouin’s solution. Paraffin sections (5 mm)
were deparaffinized, rehydrated, and stained with periodic acid Schiff
(PAS)/hematoxylin or hematoxylin/eosin. For the detection of sperm in
epididymides, sections were stained with Hoechst 33358. For detec-
tion of phospho-histone H3, sections were blocked in PBS plus 5%
BSA, then stained with rabbit anti-phospho-histone H3 antibody
(1:50) overnight at 4C. Following washes in PBS, sections were
stained with an Alexa488-labeled secondary antibody (Molecular
Probes) diluted 1:500, stained with Hoechst 33358, and then mounted.
Following timed matings, pregnant females were injected (i.p.) at 10.5
days p.c. with tamoxifen (5 mg per 40 g body weight) dissolved in corn
oil and then sacrificed on day 18.5. The animal studies were carried out
according to Home Office and Institutional guidelines.
Supplemental Data
The Supplemental Data include seven figures, two tables, and
Supplemental Experimental Procedures and can be found with this
article online at http://www.developmentalcell.com/cgi/content/full/
13/4/566/DC1/.
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